← Back to headlines
Roivant Anticipates $950M Moderna Payment, Outlines Drug Readouts
Roivant Sciences expects to receive a $950 million payment from Moderna in July and has outlined readouts for its mosliciguat and IMVT-1402 drug candidates in the second half of 2026.
20 May, 22:21 — 20 May, 22:21
Sources
Showing 1 of 1 sources
